NEP-018

N/A

Report date: 2025/03/03 17:00:01
NME

Base Information

Drug NameNEP-018
Drug Alias NameNEP018NEP-018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTropomyosin-related kinase inhibitorsVascular endothelial growth factor receptor antagonistsHepatocyte growth factor receptor inhibitors
TargetsTropomyosin-related kinaseVascular endothelial growth factor receptorHepatocyte growth factor receptor
Therapy Area/IndicationsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenzhen Neptunus Pharmaceutical Research Institute Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShenzhen Neptunus Pharmaceutical Research Institute Co Ltd
Inactive CompaniesN/A
Active IndicationsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A